NorthWest Biotherapeutics Inc (NWBO)

[10baggerz]

Haha beat me to it (BTW couldn’t agree more that the interim blended blended OS results are fantastic):

Median OSFrom Surgery
Survival at1 year
Survival at2 years
Survival at3 years
2017 data
23.1 months
89.3%
46.2%
25.4%
2018 data
23.1 months
89.3%
46.4%
28.2%

Median OSFrom Surgery
Survival at1 year
Survival at2 years
Survival at3 years
2017 methylated
34.7 months
94.5%
66.7%
46.4%
2018 methylated
35.1 months
94.6%
66.6%
49.1%

Source:
https://nwbio.com/updated-interim-data-from-phase-3-trial-of-dcvax-l-for-glioblastoma/